AquaBounty Technologies, Inc. (NASDAQ:AQB – Get Free Report) passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $0.99 and traded as low as $0.89. AquaBounty Technologies shares last traded at $0.9899, with a volume of 49,163 shares traded.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of AquaBounty Technologies in a report on Wednesday, July 8th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has a consensus rating of “Sell”.
View Our Latest Research Report on AQB
AquaBounty Technologies Stock Up 8.8%
Institutional Trading of AquaBounty Technologies
An institutional investor recently bought a new stake in AquaBounty Technologies stock. Two Sigma Investments LP acquired a new position in shares of AquaBounty Technologies, Inc. (NASDAQ:AQB – Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 37,565 shares of the company’s stock, valued at approximately $84,000. Two Sigma Investments LP owned 0.97% of AquaBounty Technologies at the end of the most recent reporting period. Institutional investors own 8.92% of the company’s stock.
About AquaBounty Technologies
AquaBounty Technologies, Inc is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.
Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama.
See Also
- Five stocks we like better than AquaBounty Technologies
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Receive News & Ratings for AquaBounty Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AquaBounty Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
